Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Cartesian Therapeutics
- ID
- NCT04146051
- Phase
- Phase 2 Myasthenia Gravis Research Study
- Study Type
- Interventional
- Participants
- Expecting 30 study participants
- Last Updated